Data / Form D filings / Rallybio Corp
Rallybio Corp: Form D filings
Rallybio Corp, a pharmaceuticals company in New Haven, CT, filed 4 Form D notices with the SEC between 2018 and 2024. The latest, on April 22, 2024, reports $6.6 million sold of a $6.6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 234 CHURCH STREET, SUITE 1020, New Haven, CT, 06510
- Phone
- (203) 859-3820
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739410
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | New notice | $6,600,000 | $6,600,000 | 1 | Apr 10, 2024 | sec.gov | |
| May 29, 2020 | Amendment | $145,204,965 | $145,204,965 | 28 | Mar 27, 2020 | sec.gov | |
| Apr 13, 2020 | New notice | $130,000,000 | $93,204,986 | $36,795,014 | 24 | Mar 27, 2020 | sec.gov |
| May 7, 2018 | New notice | $5,999,999 | $5,999,999 | 7 | Apr 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MARTIN W. MACKAY | Director | |
| PAULA M. SOTEROPOULOS | Director | |
| KUSH M. PARMAR | Director | |
| CHRISTINE A. NASH | Director | |
| HUI M. LIU | Director | |
| LUCIAN M. IANCOVICI | Director | |
| RONALD M. HUNT | Director | |
| ROB K. HOPFNER | Director | |
| WENDY K. CHUNG | Director | |
| HELEN M. BOUDREAU | Director | |
| STEPHEN UDEN | Executive Officer, Director | |
| JONATHAN I. LIEBER | Executive Officer |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Rallybio Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.